FDA mulls compounding for peptides previously flagged over safety risks BioSpace The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step The peptide conversation is shifting. Secretary RFK Jr. recently announced that the FDA plans to move 14 peptides from Category 2 back to Category 1 restoring FDA recognized status and making them FDA Peptide Update: Category 2 Removals Explained FDA May Reverse Ban on 14 PeptidesWhat It Means for Your Beauty Routine Allure